NewslettersImmunology of Infectious Disease NewsQuantum Leap Healthcare Collaborative Announce Termination of the Cyproheptadine Treatment Arm for Critically Ill COVID-19 Patients in the I-Spy COVID TrialBy Laurisa Dohm - January 4, 2023035Quantum Leap Healthcare Collaborative, sponsor of the I-SPY COVID Trial, announced that the cyproheptadine arm of the study has been terminated.[PR Newswire]Press Release